Cassey D. Bauer

Array ( [id] => 6083612 [patent_doc_number] => 20110144018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'AGENT FOR PROPHYLAXIS OF REFLEX SYMPATHETIC DYSTROPHY AFTER CEREBRAL APOPLEXY' [patent_app_type] => utility [patent_app_number] => 13/030494 [patent_app_country] => US [patent_app_date] => 2011-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7526 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144018.pdf [firstpage_image] =>[orig_patent_app_number] => 13030494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8065013 [patent_doc_number] => 20110244516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Rage Fusion Proteins And Methods Of Use' [patent_app_type] => utility [patent_app_number] => 13/029622 [patent_app_country] => US [patent_app_date] => 2011-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 28736 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20110244516.pdf [firstpage_image] =>[orig_patent_app_number] => 13029622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511393 [patent_doc_number] => 20110257103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'Compositions and methods for the treatment of sj?rgren\'s syndrome' [patent_app_type] => utility [patent_app_number] => 12/931601 [patent_app_country] => US [patent_app_date] => 2011-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18468 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257103.pdf [firstpage_image] =>[orig_patent_app_number] => 12931601 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710823 [patent_doc_number] => 08835391 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Alpha B-crystallin as a therapy for multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 12/931001 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 15 [patent_no_of_words] => 17061 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12931001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958535 [patent_doc_number] => 20110182922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'PEPTIDES OF IL1 BETA AND TNF ALPHA AND METHOD OF TREATMENT USING SAME' [patent_app_type] => utility [patent_app_number] => 13/004526 [patent_app_country] => US [patent_app_date] => 2011-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3810 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182922.pdf [firstpage_image] =>[orig_patent_app_number] => 13004526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6185294 [patent_doc_number] => 20110124102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Rage Fusion Proteins And Methods Of Use' [patent_app_type] => utility [patent_app_number] => 12/986602 [patent_app_country] => US [patent_app_date] => 2011-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 28737 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124102.pdf [firstpage_image] =>[orig_patent_app_number] => 12986602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10850514 [patent_doc_number] => 08877192 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-04 [patent_title] => 'Rage fusion proteins and methods of use' [patent_app_type] => utility [patent_app_number] => 12/983604 [patent_app_country] => US [patent_app_date] => 2011-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 28735 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 225 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12983604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159537 [patent_doc_number] => 20110158986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'HUMANIZED ANTIBODIES THAT SEQUESTER AMYLOID BETA PEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/976282 [patent_app_country] => US [patent_app_date] => 2010-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16504 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20110158986.pdf [firstpage_image] =>[orig_patent_app_number] => 12976282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250150 [patent_doc_number] => 08613928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Immunizing composition and method for inducing an immune response against the β-secretase cleavage site of amyloid precursor protein' [patent_app_type] => utility [patent_app_number] => 12/961248 [patent_app_country] => US [patent_app_date] => 2010-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 17359 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12961248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039386 [patent_doc_number] => 20110092435 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'TREATMENT OF PARKINSON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/949597 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20601 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092435.pdf [firstpage_image] =>[orig_patent_app_number] => 12949597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127675 [patent_doc_number] => 20110086804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'TREATMENT OF PARKINSON\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 12/949636 [patent_app_country] => US [patent_app_date] => 2010-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20601 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086804.pdf [firstpage_image] =>[orig_patent_app_number] => 12949636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6079887 [patent_doc_number] => 20110142763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Megalin-Based Delivery of Therapeutic Compounds to the Brain and Other Tissues' [patent_app_type] => utility [patent_app_number] => 12/941619 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 41270 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142763.pdf [firstpage_image] =>[orig_patent_app_number] => 12941619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8244914 [patent_doc_number] => 08202840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-19 [patent_title] => 'Enhanced ocular neuroprotection and neurostimulation' [patent_app_type] => utility [patent_app_number] => 12/914615 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 10835 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/202/08202840.pdf [firstpage_image] =>[orig_patent_app_number] => 12914615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055674 [patent_doc_number] => 20110112034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Modulation of synaptogenesis' [patent_app_type] => utility [patent_app_number] => 12/925486 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17184 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112034.pdf [firstpage_image] =>[orig_patent_app_number] => 12925486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8853117 [patent_doc_number] => 20130142792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'RAGE Fusion Protein Compositions And Methods Of Use' [patent_app_type] => utility [patent_app_number] => 13/062395 [patent_app_country] => US [patent_app_date] => 2010-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 79 [patent_figures_cnt] => 79 [patent_no_of_words] => 37027 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13062395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000677 [patent_doc_number] => 20110117092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING G-CSFR' [patent_app_type] => utility [patent_app_number] => 12/906548 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23923 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117092.pdf [firstpage_image] =>[orig_patent_app_number] => 12906548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6195527 [patent_doc_number] => 20110027281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'SINGLE DOMAIN ANTIBODIES DIRECTED AGAINST TUMOR NECROSIS FACTOR-ALPHA AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/905589 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 26104 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027281.pdf [firstpage_image] =>[orig_patent_app_number] => 12905589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10863450 [patent_doc_number] => 08889138 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Anti-ADDL antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/901738 [patent_app_country] => US [patent_app_date] => 2010-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 99 [patent_no_of_words] => 25554 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12901738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483230 [patent_doc_number] => 20120282637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'POLYPEPTIDES FOR BINDING TO THE RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS AS WELL AS COMPOSITIONS AND METHODS INVOLVING' [patent_app_type] => utility [patent_app_number] => 13/500400 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14443 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148701 [patent_doc_number] => 20110020296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'METHODS FOR TREATING DISEASES AND INCREASING LONGEVITY' [patent_app_type] => utility [patent_app_number] => 12/897919 [patent_app_country] => US [patent_app_date] => 2010-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22246 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020296.pdf [firstpage_image] =>[orig_patent_app_number] => 12897919 [rel_patent_id] =>[rel_patent_doc_number] =>)